These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14592831)

  • 61. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.
    Jiang A; Fisher H; Pomerantz RJ; Dornburg R
    Hum Gene Ther; 1999 Nov; 10(16):2627-36. PubMed ID: 10566890
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CD4 activation of HIV fusion.
    Sattentau QJ
    Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes.
    Barrero-Villar M; Cabrero JR; Gordón-Alonso M; Barroso-González J; Alvarez-Losada S; Muñoz-Fernández MA; Sánchez-Madrid F; Valenzuela-Fernández A
    J Cell Sci; 2009 Jan; 122(Pt 1):103-13. PubMed ID: 19066282
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchange.
    Cerutti N; Mendelow BV; Napier GB; Papathanasopoulos MA; Killick M; Khati M; Stevens W; Capovilla A
    J Biol Chem; 2010 Aug; 285(33):25743-52. PubMed ID: 20538591
    [TBL] [Abstract][Full Text] [Related]  

  • 66. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
    Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
    J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
    [TBL] [Abstract][Full Text] [Related]  

  • 67. T-tropic human immunodeficiency virus type 1 (HIV-1)-derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infection.
    Sakaida H; Hori T; Yonezawa A; Sato A; Isaka Y; Yoshie O; Hattori T; Uchiyama T
    J Virol; 1998 Dec; 72(12):9763-70. PubMed ID: 9811711
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evidence for cell surface association between CXCR4 and ganglioside GM3 after gp120 binding in SupT1 lymphoblastoid cells.
    Sorice M; Garofalo T; Misasi R; Longo A; Mattei V; Sale P; Dolo V; Gradini R; Pavan A
    FEBS Lett; 2001 Sep; 506(1):55-60. PubMed ID: 11591370
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes.
    Balabanian K; Harriague J; Décrion C; Lagane B; Shorte S; Baleux F; Virelizier JL; Arenzana-Seisdedos F; Chakrabarti LA
    J Immunol; 2004 Dec; 173(12):7150-60. PubMed ID: 15585836
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptors.
    Hoffman TL; Canziani G; Jia L; Rucker J; Doms RW
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11215-20. PubMed ID: 11005830
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment.
    Melikyan GB; Platt EJ; Kabat D
    Retrovirology; 2007 Aug; 4():55. PubMed ID: 17686153
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation.
    Bandres JC; Wang QF; O'Leary J; Baleaux F; Amara A; Hoxie JA; Zolla-Pazner S; Gorny MK
    J Virol; 1998 Mar; 72(3):2500-4. PubMed ID: 9499113
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The function of coreceptor as a basis for the kinetic dissection of HIV type 1 envelope protein-mediated cell fusion.
    Chien MP; Jiang S; Chang DK
    FASEB J; 2008 Apr; 22(4):1179-92. PubMed ID: 18032634
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
    Finnegan CM; Berg W; Lewis GK; DeVico AL
    J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.
    Pacheco B; Alsahafi N; Debbeche O; Prévost J; Ding S; Chapleau JP; Herschhorn A; Madani N; Princiotto A; Melillo B; Gu C; Zeng X; Mao Y; Smith AB; Sodroski J; Finzi A
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28003492
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains.
    Nehete PN; Vela EM; Hossain MM; Sarkar AK; Yahi N; Fantini J; Sastry KJ
    Antiviral Res; 2002 Dec; 56(3):233-51. PubMed ID: 12406507
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4.
    Espert L; Denizot M; Grimaldi M; Robert-Hebmann V; Gay B; Varbanov M; Codogno P; Biard-Piechaczyk M
    J Clin Invest; 2006 Aug; 116(8):2161-72. PubMed ID: 16886061
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fusion Stage of HIV-1 Entry Depends on Virus-Induced Cell Surface Exposure of Phosphatidylserine.
    Zaitseva E; Zaitsev E; Melikov K; Arakelyan A; Marin M; Villasmil R; Margolis LB; Melikyan GB; Chernomordik LV
    Cell Host Microbe; 2017 Jul; 22(1):99-110.e7. PubMed ID: 28704658
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor.
    Doranz BJ; Grovit-Ferbas K; Sharron MP; Mao SH; Goetz MB; Daar ES; Doms RW; O'Brien WA
    J Exp Med; 1997 Oct; 186(8):1395-400. PubMed ID: 9334380
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis.
    Yao Q; Compans RW; Chen C
    Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.